Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
12-CdA, 2-chloro-2'-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
22-CdA, 2-chloro-2'-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
32-CdA, 2-chloro-2?-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
42-CdA, 2-chloro-2?-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
52-CdA, 2-chloro-2’-deoxy-beta-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
62-CdA, 2-chloro-2’-deoxy-ß-D-adenosine[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
72-chloro-2'-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
82-chloro-2'-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
92-chloro-2?-deoxy-beta-D-adenosine[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
102-chloro-2?-deoxy-ß-D-adenosine[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
112-chloro-2’-deoxy-beta-D-adenosine[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
132-chloro-2’-deoxy-ß-D-adenosine[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
142-chloro-2’-deoxy-ß-D-adenosine (2-CdA)[2] Adenosine,
Cladribine
[2] D00045 (Name: Adenosine),
D01370
[5] ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬
[17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
15Adenosine[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 13, 58, 65
16Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)[1] Adenosine[1] D00045 (Name: Adenosine)[4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 65